Advances in Corneal Management

Dear Colleagues,

Corneal disease and transplantation have represented prominent topics of interest since ancient times, with the first methods for corneal transplantation dating back to the ancient Greek physician Galen. The first successful human corneal transplantation was performed in 1905 by Eduard Zinn, and, since then, progress in this field has been remarkable. However, in some cases, the management and treatment of numerous corneal conditions/illnesses, such as keratoconus, Fuchs’ dystrophy, corneal ulcers, infections, and various traumas, remains a challenge. As these disorders affect millions of people globally and frequently result in severe visual impairment, novel therapeutic strategies are required.

In addition to the above, this Special Issue will also focus on novelties in the field of refractive surgery, which has revolutionized vision correction. While advancements in corneal remodeling techniques continue to evolve, together with new possibilities, they also bring with them many challenges.

Our aim in launching this Special Issue is to present novel and original research, reviews, and clinical studies in the field of corneal diseases/conditions, corneal transplantation, and refractive surgery in order to provide an overview of current knowledge, therapeutic options, and future research directions in this field. We are eager to publish not only clinical work but also pre-clinical and laboratory research that can help us understand the mechanisms responsible for corneal pathology and its treatment. Studies exploring novel diagnostic tools and therapeutic approaches are particularly welcome.

We look forward to advancing and developing research on corneal illness and transplantation, in addition to refractive surgery, by bringing together innovative studies and a range of viewpoints.

Dr. Sanja Masnec
Prof. Dr. Rafael I. Barraquer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.